The 25 analysts offering 12-month price forecasts for Zimmer Biomet Holdings Inc have a median target of 155.00, with a high estimate of 175.00 and a low estimate of 99.00. The median estimate represents a +9.15% increase from the last price of 142.00.
The current consensus among 28 polled investment analysts is to Buy stock in Zimmer Biomet Holdings Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.07
Reporting Date Nov 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.